Safety of Floracid (Levofloxacin), a Russian Antimicrobial, in the Treatment of Outpatients

QR Code

Safety of Floracid (Levofloxacin), a Russian Antimicrobial, in the Treatment of Outpatients

Saved in:

Bibliographic Details
Main Author:	S. V. Budanov
Format:	Article
Language:	Russian
Published:	LLC "Publishing House OKI" 2020-05-01
Series:	Антибиотики и Химиотерапия
Online Access:	https://www.antibiotics-chemotherapy.ru/jour/article/view/277
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Levofloxacin (Tavanic) in Complex Therapy of Tuberculosis
by: G. B. Sokolova, et al.
Published: (2020-05-01)

PRODUCTION AND INVESTIGATION OF PROPERTIES OF LIPOSOMAL LEVOFLOXACIN
by: G. М. Sorokoumova, et al.
Published: (2013-10-01)

Levofloxacin: Analysis of Information on Adverse Reactions from Russian Spontaneous Report Database
by: S. K. Zyryanov, et al.
Published: (2020-05-01)

Comparative Analysis of the Use of Antimicrobials With Systemic Action in Outpatients in the Russian Federation, Ukraine and Kazakhstan
by: S. A. Rachina, et al.
Published: (2020-05-01)

Dynamics of Reserve Antimicrobial Drug Consumption in Russian Hospitals: Impact of the COVID-19 Pandemic
by: Y. M. Gomon, et al.
Published: (2023-10-01)

Assessing insurance claims as a measure for outpatient antimicrobial stewardship
by: Mariana M. Lanata, et al.
Published: (2025-01-01)

Synthesis a Number of Heterocyclic Compounds Derived From Levofloxacin
by: Ekram Abdullah Basheer, et al.
Published: (2023-02-01)

First experience with a fixed combination of levofloxacin and ketorolac in cataract surgery
by: V. P. Nikolaenko, et al.
Published: (2025-03-01)

Magnesium Orotate Influence on Thoracic Aorta in Laboratory Rabbits Receiving Levofloxacin
by: N. V. Izmozherova, et al.
Published: (2024-10-01)

Levofloxacin loaded PMMA:PVP blended nanofiber mat as an antibacterial material
by: V A Karachevtsev, et al.
Published: (2025-01-01)

HPLC determination, pharmacokinetics and relative bioavailability of levofloxacin produced by «OZONE», Russia
by: S. N. Kondratenko, et al.
Published: (2013-04-01)

Pharmacoeconomic analysis of first-choice antimicrobial drugs prescribed for outpatient treatment of non-severe community-acquired pneumonia
by: V. G. Deriushkin, et al.
Published: (2021-02-01)

Synthesis a Number of Heterocyclic Compounds and some of chalcones Derived From Levofloxacin
by: Ekram Abdullah Basheer, et al.
Published: (2023-02-01)

Levofloxacin. Expediency of High-Dose Regimens in Therapy of Lower Respiratory Tract Infections
by: I. A. Guchev, et al.
Published: (2020-05-01)

VALIDATION OF UV-SPECTROMETRY ASSAY METHOD FOR DISSOLUTION PROFILE TEST FOR LEVOFLOXACINE TABLETS
by: A. A. Lvova, et al.
Published: (2019-01-01)

Medication Errors Associated with the Use of Levofloxacin: An Analysis of the National Database of Spontaneous Reports
by: I. L. Asetskaya, et al.
Published: (2025-04-01)

Evaluation of the effect of Levofloxacin and Cefalexin derivative antibiotics on Implant Osseointegration in rat tibia
by: Umit Koray Can, et al.
Published: (2025-07-01)

Key issues of patient safety during anticancer drug treatment in a day hospital and outpatient setting
by: A. A. Fedenko, et al.
Published: (2021-11-01)

THE STUDY THE EFFICACY AND SAFETY OF ANTIMICROBIAL AGENTS
by: V. V. Bagaeva, et al.
Published: (2015-10-01)

Early adopters of 6-month levofloxacin as rifampicin-resistant tuberculosis preventive treatment regimen in the WHO European Region, 2023
by: Andrei Dadu
Published: (2025-07-01)

CAPITAL ACCUMULATION IN THE PROCESS OF DEVELOPMENT OF THE ARCTIC ZONE OF THE RUSSIAN FEDERATION
by: I. A. Budanov
Published: (2016-04-01)

Possibilities of increase of efficiency and tolerance of antimicrobial therapy of pelvic inflammatory diseases in the practice of outpatient gynecologist-obstetrician
by: E. V. Domanova
Published: (2021-06-01)

Prospects of Levofloxacin Use in Therapy of Patients with Bronchopulmonary Diseases or Skin and Soft Tissue Pyo-Inflammatory Lesions
by: V. I. Sokolova, et al.
Published: (2020-05-01)

EPIDEMIOLOGY OF UNCOMPLICATED OUTPATIENT URINARY TRACT INFECTIONS IN THE RUSSIAN FEDERATION
by: V. V. Rafalsky, et al.
Published: (2018-07-01)

Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia
by: I. A. Vilyum, et al.
Published: (2018-05-01)

RETRACTED: Two-day seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial
by: Salma Messous, et al.
Published: (2022-06-01)

Microbiological Surveillance and Antimicrobial Susceptibility Observations on Peritoneal Dialysis-Associated Peritonitis in an Outpatient German Reference Center
by: Annemarie Albert, et al.
Published: (2025-05-01)

Efficacy and safety of statin therapy in multimorbid outpatients with very high cardiovascular risk
by: N. V. Izmozherova, et al.
Published: (2020-07-01)

Clinical Pharmacology of Antimicrobials: Focus on the Safety of Vancomycin and Linezolid
by: M. V. Zhuravleva, et al.
Published: (2023-12-01)

Use of Antidepressant for the Treatment of Depression in CAMHS Outpatient
by: Chidimma Orji, et al.
Published: (2025-06-01)

Evaluation of the outpatient parenteral antimicrobial therapy (OPAT) service in Malaysian public hospitals: a mixed-methods study protocol
by: Nor Arisah Misnan, et al.
Published: (2025-06-01)

TREATMENT QUALITY OF PATIENTS WITH ARTERIAL HYPERTENSION IN THE OUTPATIENT SETTING
by: O. V. Poltoratskaya
Published: (2003-12-01)

Retraction: “Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial”
Published: (2025-07-01)

Outpatient Clinic of Russian Red Cross in Berlin in 1920s —1930s
by: K. D. Kotelnikov
Published: (2021-08-01)

Incidence and risk factors for musculoskeletal adverse effects associated with daptomycin in patients receiving outpatient parenteral antimicrobial therapy
by: Meaghen B. Wiley, et al.
Published: (2025-01-01)

Adsorption study of fluoroquinolone antibiotic - levofloxacin to evaluate the possibility of its removal from wastewaters using natural zeolite
by: I. Rubashvili, et al.
Published: (2023-11-01)

Design of Potentiometric Sensor Based on Molecularly-imprinted Polymer for Direct Detection of Levofloxacin in Plasma for Point-of-Care Applications
by: Amr M. Mahmoud, et al.
Published: (2024-05-01)

Barriers to effective outpatient hypertension treatment: a view of physicians and patients
by: S. V. Nedogoda, et al.
Published: (2020-05-01)

Some aspects of the treatment of constipation in therapeutic outpatient practice
by: A. A. Stremoukhov, et al.
Published: (2023-12-01)

Anti-Mutant Efficacy of Combination Therapy with Doripenem and Levofloxacin: <i>In Vitro</i> Model Studies with <i>Pseudomonas Aeruginosa</i>
by: M. V. Golikova, et al.
Published: (2021-06-01)